Sign in

CIK 0001668243

  • Non-accelerated filer
  • Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 97707601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,037,646
in 4 filings

Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-09-09 Smith Jason Drew General Counsel Option exercise +3,333 26,747
2024-09-09 Smith Jason Drew General Counsel Sale −1,521 $13.08 $20K 25,226
2024-09-09 Smith Jason Drew General Counsel Option exercise · Restricted Stock Units −3,333 6,667
2024-09-09 Kim Dong Chief Financial Officer Option exercise +2,500 37,753
2024-09-09 Kim Dong Chief Financial Officer Option exercise · Restricted Stock Units −2,500 5,000
2024-08-06 Belldegrun Arie Director Grant or award · Stock Option (right ot buy) +10,000 10,000
2024-08-06 Cohen Fred E Director Grant or award · Stock Option (right ot buy) +10,000 10,000
2024-08-06 Wildman Daniel George Director Grant or award · Stock Option (right ot buy) +10,000 10,000
2024-08-06 Holden Stuart Director Grant or award · Stock Option (right ot buy) +10,000 10,000
2024-08-06 Robinson James A. Jr. Director Grant or award · Stock Option (right ot buy) +10,000 10,000
2024-08-06 WEN LEANA Director Grant or award · Stock Option (right ot buy) +10,000 10,000
2024-08-06 BUTITTA CYNTHIA M Director Grant or award · Stock Option (right ot buy) +10,000 10,000
2024-06-10 Schoenberg Mark Chief Medical Officer Option exercise +10,000 149,437
2024-06-10 Schoenberg Mark Chief Medical Officer Sale −5,153 $13.08 $67K 144,284
2024-06-10 Schoenberg Mark Chief Medical Officer Option exercise · Restricted Stock Units −10,000 20,000
2024-03-18 Schoenberg Mark Chief Medical Officer Sale −12,000 $14.05 $169K 139,437
2024-02-01 Smith Jason Drew General Counsel Sale −417 $15.78 $7K 18,824
2024-02-01 Smith Jason Drew General Counsel Sale −1,248 $15.78 $20K 20,076
2024-02-01 Smith Jason Drew General Counsel Sale −3,328 $15.78 $53K 23,414
2024-02-01 Schoenberg Mark Chief Medical Officer Sale −1,137 $15.78 $18K 149,423

Page 7 of 13 · 244 trades